|
|
|
市場調查報告書
美國的體外照射療法市場：2010年
2011 U.S. MARKETS FOR EXTERNAL RADIATION THERAPY
|
美國的體外照射療法市場：2010年 是由出版商Life Science Intelligence, Inc.在2011年05月所出版的。
這份英文市場調查報告書價格從美金3900起跳。
本報告書內容包括:美國的體外照射療法市場的相關所有市場智慧解決方案。高品質且詳細的最新資料及每6個月的定期更新等的提供。
第1章 既存的技術和特徵和新興技術
- 既存技術的特徴
- 既存技術的課題
- 適合性
- 無氧氣組織
- 經濟的要因
- 補助和國家的政策及計畫
- 系統價格和相關費用
- 全球經濟
第2章 美國的體外照射療法市場
- 市場預測：2007∼2013年
- 供應商佔有率：2008年
- 線形加速器及伽瑪射線設備市場的影響因素
- 美國的體外照射療法：線形加速器及伽瑪射線設備：2007∼2013年
- 線形加速器及伽瑪射線設備的美國佔有率：2008年
- 美國的各系統市場預測：2007∼2013年
- 線形加速器及伽瑪射線設備：2008年及2013年
- 不景氣的影響：線形加速器及伽瑪射線設備
- 體外照射療法和SRS市場：2007∼2013年
- 體外照射療法和SRS市場的影響因素：2007∼2013年
- 各用途市場預測：2007∼2013年
- SRS及體外照射療法設備：2008年及2013年
- 不景氣的影響：SRS設備
- 定位性放射線治療：美國患者人數：2007∼2013年
- 定位性放射線治療：美國各種類患者趨勢：2007∼2013年
- 頭蓋外定位性放射線治療：美國患者人數：2007∼2013年
- 定位性放射線治療：美國的處理件數：2007∼2013年
- 定位性放射線治療：美國的各種類處理件數：2007∼2013年
- 不景氣的影響：頭蓋外定位性放射線治療
- 體外照射療法所治療的乳癌・肺癌・前列腺癌患者數：2007∼2013年
- 陽子線治療：美國市場預測：2007∼2013年
- 陽子線治療装置：美國供應商佔有率：2008年
- 陽子線治療：患者趨勢：2007∼2013年
- 陽子線治療：美國處理件數：2007∼2013年
第3章 合併・收購・聯盟
第4章 新興企業
Abstract
“2011 U.S. MARKETS FOR EXTERNAL RADIATION THERAPY” is a
comprehensive, total market intelligence solution designed for senior
executives who are looking for:
- High quality, granular, deeply segmented data
- Access to senior LSI analysts to conduct proprietary modeling and custom
market simulations
- Access to useable source data for in-house customization and adoption of
market models
This product is a complete market intelligence solution.
The deliverables include:
|
|
- Initial report with most recent data available (PDF and Excel)
- Extensive access to senior LSI analyst for proprietary add-on analysis
- Online platform making the data useable and interactive
|
About Life Science Intelligence
Life Science Intelligence (LSI) delivers high quality market reports, market
agents, procedure databases, company databases, online partnering events, and
custom consulting services to medical technology executives, investors, and
entrepreneurs. LSI produces its own information products and partners with
select top-tier information companies to distribute their products.
Table of Contents
1. ESTABLISHED AND EMERGING TECHNOLOGIES
- 1.1. Features of Established Technologies
- 1.2. Challenges for Established Technologies
- 1.2.1. Conformality
- 1.2.2. Anoxic Tissues
- 1.2.2.1. Economic Factors
- 1.2.2.1.1. Reimbursement and National Policies and Initiatives
- 1.2.2.1.2. System Prices & Associated Costs
- 1.2.2.1.3. The Global Economy
- Exhibit 1-1: External Radiation Therapy by Type
- Exhibit 1-2: Advantages and Disadvantages of External Radiation Therapy
Systems
- Exhibit 1-3: Features of Linear Accelerator and Gamma-Ray Systems Used for
External Radiation Therapy and SRS
- Exhibit 1-4: Features of Particle Therapy Centers
- Exhibit 1-5: Challenges Associated with Available Technologies
- Exhibit 1-6: Established and Emerging Technologies
2. U.S. MARKETS FOR EXTERNAL RADIATION THERAPY
- Exhibit 2-1: External Radiation Therapy, U.S. Market Forecast, 2007-2013
- Exhibit 2-2: External Radiation Therapy, Supplier Shares, 2008
- Exhibit 2-3: Factors Influencing the U.S. Market for Linear Accelerator &
Gamma-Ray Systems from 2007-2013
- Exhibit 2-4: U.S. External Radiation Therapy, Linear Accelerators &
Gamma-Ray Systems, 2007-2013
- Exhibit 2-5: Linear Accelerator & Gamma-Ray Systems, U.S. Shares, 2008
- Exhibit 2-6: U.S. Market Forecast by Type of System, Linear Accelerator
and Gamma-Ray Systems, 2007-2013
- Exhibit 2-7: Linear Accelerator and Gamma-Ray Systems, 2008 & 2013
- Exhibit 2-8: Impact of the Recession: Gamma-Ray Systems and Linear
Accelerators, 2007-2013
- Exhibit 2-9: Factors Influencing the U.S. Market for External Radiation
Therapy and SRS from 2007-2013
- Exhibit 2-10: External Radiation Therapy, U.S. Market Forecast by
Application, 2007-2013
- Exhibit 2-11: SRS and External Radiation Systems, 2008 & 2013
- Exhibit 2-12: Impact of the Recession: SRS Systems, 2007-2013
- Exhibit 2-13: Stereotactic Radiosurgery - U.S. Patient Volumes, 2007-2013
- Exhibit 2-14: Stereotactic Radiosurgery - U.S. Patient Volumes by Type,
2007-2013
- Exhibit 2-15: Stereotactic Radiosurgery - Utilization by Patient Type,
2007-2013
- Exhibit 2-16: Extracranial Stereotactic Radiosurgery - U.S. Patient
Volumes, 2007-2013
- Exhibit 2-17: Stereotactic Radiosurgery - U.S. Procedure Volumes, 2007-2013
- Exhibit 2-18: Stereotactic Radiosurgery - U.S. Procedures by Type,
2007-2013
- Exhibit 2-19: Stereotactic Radiosurgery - Utilization by Procedure,
2007-2013
- Exhibit 2-20: Extracranial Stereotactic Radiosurgery - U.S. Procedure
Volumes, 2007-2013
- Exhibit 2-21: Impact of the Recession: External Radiation Therapy Systems,
2007-2013.
- Exhibit 2-22: New Cancer Cases in the U.S by Anatomical Location, 2007-2013
- Exhibit 2-23: Breast, Lung and Prostate Patients Treated with External
Radiation Therapy in the U.S., 2007-2013
- Exhibit 2-24: Other Patients Treated with External Radiation Therapy,
2007-2013
- Exhibit 2-25: External Radiation Therapy in the U.S., Breast, Lung, and
Prostate Procedures, 2007-2013
- Exhibit 2-26: Other External Radiation Therapy Procedures in the U.S.,
2007-2013
- Exhibit 2-27: Factors Influencing the U.S. Market for Proton Therapy,
2007-2013
- Exhibit 2-28: Proton Therapy, U.S. Market Forecast, 2007-2013
- Exhibit 2-29: Proton Therapy Systems, U.S. Supplier Shares in 2008
- Exhibit 2-30: Proton Therapy, U.S. Patient Volumes, 2007-2013
- Exhibit 2-31: Proton Therapy, U.S. Procedure Volumes, 2007-2013
3. MERGERS, ACQUISITIONS, AND PARTNERSHIPS
4. EMERGING COMPANIES
|
 |
